Literature DB >> 21822362

De-N-acetylated sialic acid is immunogenic and elicits antibodies that are protective against Neisseria meningitidis.

Gregory R Moe1, Becca A Flitter, Jessica Y Ing, Tamara S Bhandari, Hardeep Kaur.   

Abstract

Recently, we showed that monoclonal antibodies (mAbs) that are reactive with derivatives of polysialic acid containing de-N-acetylated neuraminic acid (Neu) residues are protective against N. meningitidis group B strains (Moe et al. 2005, Infect Immun73: 2123; Flitter et al., in preparation). In addition, we found that fully de-N-acetylated PSA (i.e. poly alpha 2,8 Neu) conjugated to tetanus toxoid (DeNAc) elicits IgM and IgG antibodies of all subclasses in mice that bind to group B strains, activate human complement deposition, are protective in an infant rat model of meningococcal bacteremia and are bactericidal against group C strains (Moe et al, in press). We show here that anti-DeNAc mAbs, DA1 and DA2 (both IgM), are reactive with polysaccharides containing Neu, bind to group B, C, W135 and Y but not X strains grown in chemically defined media (CDM). However, when the group X strain is grown in CDM supplemented with human plasma, DA2 binds. Also both mAbs mediate bactericidal activity against B, C, W135, and X strains with human complement. The results suggests that N. meningitidis express and/or acquire zwitterionic de-N-acetyl sialic acid antigens that can be the target of protective antibodies.

Entities:  

Year:  2009        PMID: 21822362      PMCID: PMC3149888     

Source DB:  PubMed          Journal:  Vaccimonitor        ISSN: 1025-028X


  11 in total

1.  Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.

Authors:  E V Chandrasekaran; Jun Xue; Jie Xia; Robert D Locke; Khushi L Matta; Sriram Neelamegham
Journal:  Biochemistry       Date:  2007-12-08       Impact factor: 3.162

2.  Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation.

Authors:  Adam H Courtney; Erik B Puffer; Jason K Pontrello; Zhi-Qiang Yang; Laura L Kiessling
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

3.  Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.

Authors:  D M Granoff; A Bartoloni; S Ricci; E Gallo; D Rosa; N Ravenscroft; V Guarnieri; R C Seid; A Shan; W R Usinger; S Tan; Y E McHugh; G R Moe
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

4.  Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region.

Authors:  J S Swartley; J H Ahn; L J Liu; C M Kahler; D S Stephens
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

5.  Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid.

Authors:  N J Parsons; J R Andrade; P V Patel; J A Cole; H Smith
Journal:  Microb Pathog       Date:  1989-07       Impact factor: 3.738

6.  Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.

Authors:  G R Moe; P Zuno-Mitchell; S S Lee; A H Lucas; D M Granoff
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 7.  Iron transport systems in Neisseria meningitidis.

Authors:  Donna Perkins-Balding; Melanie Ratliff-Griffin; Igor Stojiljkovic
Journal:  Microbiol Mol Biol Rev       Date:  2004-03       Impact factor: 11.056

8.  Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against neisseria meningitidis groups B and C.

Authors:  Gregory R Moe; Tamara S Bhandari; Becca A Flitter
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  Polysaccharide processing and presentation by the MHCII pathway.

Authors:  Brian A Cobb; Qun Wang; Arthur O Tzianabos; Dennis L Kasper
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

Review 10.  Sialic acid utilization by bacterial pathogens.

Authors:  Emmanuele Severi; Derek W Hood; Gavin H Thomas
Journal:  Microbiology (Reading)       Date:  2007-09       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.